Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020;20(8):1133-1143.
doi: 10.2174/1871530320666200127103320.

Italian Association of Clinical Endocrinologists (AME) and Italian AACE Chapter Position Statement for Clinical Practice: Acromegaly - Part 1: Diagnostic and Clinical Issues

Affiliations
Review

Italian Association of Clinical Endocrinologists (AME) and Italian AACE Chapter Position Statement for Clinical Practice: Acromegaly - Part 1: Diagnostic and Clinical Issues

Renato Cozzi et al. Endocr Metab Immune Disord Drug Targets. 2020.

Abstract

Acromegaly is a rare disease. Improvements in lifespan in these patients have recently been reported due to transsphenoidal surgery (TSS), advances in medical therapy, and strict criteria for defining disease remission. This document reports the opinions of a group of Italian experts who have gathered together their prolonged clinical experience in the diagnostic and therapeutic challenges of acromegaly patients. Both GH and IGF-I (only IGF-I in those treated with Pegvisomant) are needed in the diagnosis and follow-up. Comorbidities (cardio-cerebrovascular disease, sleep apnea, metabolic derangement, neoplasms, and bone/joint disease) should be specifically addressed. Any newly diagnosed patient should be referred to a multidisciplinary team experienced in the treatment of pituitary adenomas.

Keywords: Acromegaly; GH; IGF-I; comorbidities; discrepant; pituitary.

PubMed Disclaimer

References

    1. Cozzi R., Baldelli R., Colao A., Lasio G., Zini M., Attanasio R., Chanson P., Giustina A., Ghigo E., Strasburger C. Italian Association of Clinical Endocrinologists (AME). AME Position Statement on clinical management of acromegaly. J. Endocrinol. Invest. 2009;32(Suppl. 6):2–25. - PubMed
    1. Atkins D., Best D., Briss P.A., Eccles M., Falck-Ytter Y., Flottorp S., Guyatt G.H., Harbour R.T., Haugh M.C., Henry D., Hill S., Jaeschke R., Leng G., Liberati A., Magrini N., Mason J., Middleton P., Mrukowicz J., O’Connell D., Oxman A.D., Phillips B., Schünemann H.J., Edejer T., Varonen H., Vist G.E., Williams J.W., Jr, Zaza S., GRADE Working Group Grading quality of evidence and strength of recommendations. BMJ. 2004;328(7454):1490–1497. doi: 10.1136/bmj.328.7454.1490. - DOI - PMC - PubMed
    1. Swiglo B.A., Murad M.H., Schünemann H.J., Kunz R., Vigersky R.A., Guyatt G.H., Montori V.M. A case for clarity, consistency, and helpfulness: state-of-the-art clinical practice guidelines in endocrinology using the grading of recommendations, assessment, development, and evaluation system. J. Clin. Endocrinol. Metab. 2008;93(3):666–673. doi: 10.1210/jc.2007-1907. - DOI - PubMed
    1. Guyatt G.H., Oxman A.D., Vist G.E., Kunz R., Falck-Ytter Y., Alonso-Coello P., Schünemann H.J., GRADE Working Group GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924–926. doi: 10.1136/bmj.39489.470347.AD. - DOI - PMC - PubMed
    1. Fernandez A., Karavitaki N., Wass J.A. 2010.

MeSH terms